About ToeFX
ToeFX is a Healthcare company based in Hamilton (Canada) founded in 2016 by Monika Yazdanian and Irit Van Ham. It operates as a treatments for toenail fungus are developed using photodynamic therapy. ToeFX has raised $30 thousand across 1 funding round from investors including Accelerator Centre. Its chief executive is Monika Yazdanian. Its focus areas include Life Sciences, Infectious Diseases, Medical Devices and Therapeutics. Its competitors include Cerus, Aethlon Medical, Amferia, Ondine Biomedical and 3Oe Scientific and 4 more; 4 of its 9 listed competitors have raised funding.
Company details
Founded in 2016 in Hamilton, Canada, ToeFX is engaged in biopharmaceutical research and development for onychomycosis treatments. Photodynamic therapy, incorporating light radiation and photosensitizers, forms the basis of its technology platform. Operations include discovery efforts and clinical advancements, supported by collaboration with McMaster University. Leadership is held by co-founder and CEO Monika Yazdanian, alongside founder and CTO Irit Van Ham.
- Total Equity Funding$30K (USD)
in 1 rounds
- Latest Funding Round$30K (USD), Seed
Jun 2019
- Investors
Funding Insights of ToeFX
ToeFX has successfully raised a total of $30K through 1 strategic funding round. The most recent funding activity was a Seed round of $30 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $30,000
- Total Rounds 1
- Last Round Seed — $30,000
- First Round $30,000
(Jun 2019)
- Investors Count 1
All 1 funding rounds of ToeFX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $30,000 | Seed | – | Accelerator Centre | – |
1 investors in total: 1 institutional.
Investors in ToeFX
ToeFX has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Accelerator Centre.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Startups are built and accelerated in a structured studio environment. | – | acceleratorcentre.com | Waterloo, Canada |
Investor details for ToeFX
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ToeFX
2 people are tracked at ToeFX (2 in leadership).
| Name | Role | Group |
|---|---|---|
Monika Yazdanian | Co-Founder & CEO | Leadership |
Irit Van Ham | Founder & CTO | Leadership |
Complete people profiles for ToeFX
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ToeFX
2 dated milestones of ToeFX across 3 years, from founding to its latest funding, stage changes and deals.
- Founded ToeFX is founded.
- Funding First funding round of $30K.
Competitors of ToeFX
ToeFX has 9 listed competitors in our database, 4 of them funded. They include Cerus, Aethlon Medical, Amferia, Ondine Biomedical and 3Oe Scientific, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cerus.com | 1991 | Concord, United States | – | 247 | Provider of pathogen inactivation technology for blood center or hospital blood bank | |
| aethlonmedical.com | 1999 | San Diego, United States | – | 14 | Hemopurification devices are developed to eliminate viruses and exosomes. | |
| amferia.com | 2018 | Gothenburg, Sweden | $3.45M | – | Anti-infective technology is developed using selective anti-bacterial polymers. | |
| ondinebio.com | 1999 | Vancouver, Canada | – | 49 | Anti-infective therapies are developed via light-activated Photodisinfection technology. | |
| 3oescientific.com | 2010 | Carmel, United States | $3.71M | – | Provider of smart solutions to manage pathogen infections | |
| laradasciences.com | 2006 | Salt Lake, United States | $2.63M | – | Head lice are removed by a network of certified professionals. | |
| pathex.co | 2016 | Nashville, United States | $5M | – | Developing blood-cleansing device to remove pathogens from circulating blood | |
| zappkit.com | 2007 | Hafnarfjordur, Iceland | – | – | Provides frequency therapy through mobile app and hardware for user health support. | |
| tcubeit.com | 2019 | Sejong, South Korea | – | – | T cell-based immuno-therapeutics for cancer and infectious diseases are developed. |
Detailed competitors of ToeFX
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
10 companies that operate in the same segment as ToeFX (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | 172 | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | 329 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ToeFX
ToeFX was founded in 2016 and raised its 1st funding round 3 years after it was founded.
ToeFX is headquartered in Hamilton, Canada. It is registered at Hamilton, Ontario, Canada.
Monika Yazdanian is the current CEO of ToeFX. They have also founded this company.
ToeFX is a funded company, having raised a total of $30K across 1 funding round to date. The company's 1st funding round was a Seed of $30K, raised on Jun 2019.
Founded in 2016 in Hamilton, Canada, ToeFX is engaged in biopharmaceutical research and development for onychomycosis treatments. Photodynamic therapy, incorporating light radiation and photosensitizers, forms the basis of its technology platform. Operations include discovery efforts and clinical advancements, supported by collaboration with McMaster University. Leadership is held by co-founder and CEO Monika Yazdanian, alongside founder and CTO Irit Van Ham.
ToeFX's top competitors include Cerus, Aethlon Medical and PATH EX.
ToeFX has 1 investor. Key investors include Accelerator Centre.